o(6)-benzylguanine has been researched along with Sarcoma in 1 studies
O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity
Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryan, CW | 1 |
| Dolan, ME | 1 |
| Brockstein, BB | 1 |
| McLendon, R | 1 |
| Delaney, SM | 1 |
| Samuels, BL | 1 |
| Agamah, ES | 1 |
| Vokes, EE | 1 |
1 trial available for o(6)-benzylguanine and Sarcoma
| Article | Year |
|---|---|
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Enzyme Inhibitors; | 2006 |